Interesting article about Biotechs from an investing

New Post Public Reply Private Reply Replies (0) Message Board
Rocco

Interesting article about Biotechs from an investing magazine.

Biotech Hits Magic Threshold

By Brian Hicks | Thursday, July 25th, 2013

2013 has already been a banner year for the biotech industry, and things promise to only get better from here...

What does all this mean to you?

Well, what it tells me — right off the bat — is that the biotech space may be headed towards a bubble.

But that shouldn't scare you.

On the contrary...

It should be getting your heart rate up right now — because bubbles are only bad when they burst.

Prior to bursting, they tend to bring investors strong, fast gains, as mainstream latecomers to the market start piling in.

One of the main features of a pre-bubble period (as illustrated by another famous bubble: the tech bubble of the early 21st century) is rapid growth within the smaller end of the market cap spectrum.

And this is exactly what's happening right now.

According to the Burrill State of the Industry Report, published for the last 27 years by Steven Burrill, CEO of Burrill & Company, smallcap biotech firms are outpacing their largecap brethren. Much of this recent expansion can be attributed to massive investment in the industry — a total of $130 billion raised in 2012.

This backing, according to Burrill, is coming less and less from high-profile IPOs, and more and more from angel investors, as well as from non-profit and government funding.

Why now?

Technology-dependent industries have a tendency to achieve bubble-caliber growth when core technologies reach levels of development that allow for rapid innovation, diversification, and product development.

We saw this very thing happen in the late 90s, when Internet connectivity and processing speeds of personal computers hit a performance threshold that made things like streaming video, secure payment processing, and real-time communications possible within the household.

The automotive industry enjoyed a similar trend with hybrid and plug-in technology, which tripled its market share between 2004 and 2009, the same period during which the financial crisis sent car buyers back to the trenches.

Today this pattern is repeating itself with biotechnology as nano-technology, computer-aided design, and molecular engineering reshape the industry.

The bubble-like conditions we're seeing today are indicative of a moment in time when the right technologies reach the right level of development in order to be synergized into a whole new generation of products and procedures.

Referred to as "the zone of convergence," it is precisely this dynamic that gave us everything from the mass-produced automobile 100 years ago... to television... to personal computers... to cellular phones...

By all indicators, this moment in time is no longer in the distance future, but quite likely already revving up.

Perhaps the biggest indicators that biotech is really hitting its stride — and possibly starting to expand the bubble — are drug approval rates, which hit a 16-year high in 2012.

Major advancements in the field include:

· Synthetic vaccines, a quantum leap over organically grown vaccines, which have been cultivated using chicken eggs since the 1930s.

· Affordable genetic sequencing, which can cost as little as $1,000 and completed 1,000 times faster (not an exaggeration) than it was in the past.

· Genetically customized cancer treatments made specifically to dovetail with a specific person's unique DNA.

· Remote patient monitoring, thanks again to the magic of the Internet and wireless technology, which will allow doctors unprecedented data gathering capabilities.

· Synthetically grown blood vessels for replacing main arteries during procedures such as cardiac bypass surgeries.

· Lab grown organs, which made their public debut in a human patient earlier this year when a two year old born without a trachea was implanted with an artificially-grown organic windpipe grown from the patient's own stem cells.

This list continues on and on, hinting quite strongly that we are already past the very first stages of the 21st century's first biotechnological renaissance.

To say that there will investment opportunities in biotech this year and in the coming years is like saying there will be weather.

However, even within what promises to be a massive field of innovations, there will be standouts...

Stay tuned in the coming months, as I get more specific and in-depth with the technologies — and the companies behind them.

Forever wealth,

Brian Hicks Signature

Brian Hicks

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 72

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 117

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 86

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 61

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 99

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 25

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Why Insurance Must Change as Family Assets Keep Growing

Updated Category News Views 32

A policy bought in the starter-home years can turn stale quietly while everything around it gets bigger, pricier and more complicated. That is the uncomfortable little truth behind Daniel C. DiCocco's discussion in HelloNation: families often treat insurance as a box checked long ago, even as they add property, savings, debt, children and fresh responsibilities. Static...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Earnings: Barfresh Food Group's Upcoming Report

Updated Category News Views 61

Anticipating Earnings: Barfresh Food Group's Upcoming Report Barfresh Food Group (NASDAQ: BRFH) is on the brink of releasing its quarterly earnings. Investors are keenly awaiting the announcement, scheduled for Thursday. As the date approaches, it is crucial to analyze the expectations and historical performance of the company. The consensus among analysts is that...

Continue Reading
Meta's Smart Glasses: AI Performance Lags Behind ChatGPT's

Updated Category News Views 563

Meta's AI Tools Tested Against ChatGPT Recently, Gene Munster from Deepwater Asset Management conducted a head-to-head comparison of Meta Platforms Inc.'s AI capabilities on its smart glasses and the performance of OpenAI's ChatGPT. His findings highlighted significant gaps between the two AI systems. ChatGPT Outshines Meta AI in Tests During the evaluation, Munster...

Continue Reading
Tractor Supply Company Expands Offerings with Allivet Acquisition

Updated Category News Views 79

Tractor Supply Company to Acquire Allivet Tractor Supply Company (NASDAQ: TSCO), the top retailer for rural lifestyle in the U.S., has made an exciting announcement regarding its latest acquisition. The company has signed a definitive agreement to acquire Allivet, an esteemed private online pharmacy specializing in pet and animal health. This strategic move aims to...

Continue Reading
20+ Companies Break Ground in Urticaria Treatment Innovations

Updated Category News Views 236

Overview of Urticaria Treatment Innovations Urticaria, commonly known as hives, is a skin condition characterized by raised, itchy welts that can vary in size and location. The increasing prevalence of urticaria has spurred significant growth in treatment options, with various companies leading clinical trials dedicated to developing new therapies. Factors contributing to...

Continue Reading
Alphabet's Unique AI Strategy: A Competitive Edge Over Rivals

Updated Category News Views 241

Alphabet's AI Transformation and Competitive Advantage Alphabet Inc. (NASDAQ: GOOGL), a leader in technology innovation, is transforming its approach to artificial intelligence. The company, trading at $319.08 per share and boasting a market capitalization of $3.79 trillion, is narrowing the valuation gap with notable competitors. Its advancements in Tensor Processing...

Continue Reading